版本:
中国

BRIEF-Aldeyra Therapeutics says results of late stage trial expected in H2 2018

April 27 Aldeyra Therapeutics Inc

* Aldeyra therapeutics announces first patient enrolled in noninfectious anterior uveitis phase 3 clinical trial

* Aldeyra therapeutics inc- results of phase 3 trial are expected in second half of 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐